PAVILION, NEW YORK (RFD NEWS) — Vive Crop Protection has announced Canadian registration of its next-generation foliar fungicide, PHO-BUS F-C 360, providing farmers in the region with enhanced disease protection for key crops.
Art Graves, Northern Agronomist for the U.S. and Canada with Vive Crop Protection, joined us on Friday’s Market Day Report to discuss what this approval means for growers. Graves explained that the fungicide offers advanced disease management options, helping Canadian farmers protect yields and maintain crop quality under challenging conditions.
PHO-BUS F-C 360 is distinguished from other foliar fungicides on the market by its next-generation formulation, designed for broader activity and improved efficacy against common crop diseases. Graves noted that comparable solutions are already available for U.S. growers, and that the innovation behind PHO-BUS F-C 360 reflects Vive Crop Protection’s commitment to developing high-performing, science-based products.
“Canadian growers are looking for solutions that deliver consistent disease control without adding complexity to their spray programs,” said Wade Clarke, national business development manager, Canada, Vive Crop Protection. “Phobos FC360 brings a clear application advantage, stronger on-leaf retention, even coverage, and proven performance across Canada. We’re excited to provide growers with another tool that helps protect yield potential and maximize the value of every acre.”
Field trials and early use have shown promising results, with growers seeing effective disease suppression and potential yield benefits. Graves also highlighted the broader mission of Vive Crop Protection, emphasizing that the company continues to bring innovative solutions to the market to help growers address evolving pest and disease pressures.
LEARN MORE: www.vivecrop.com
From Junior Heifer Shows to Mustang Magic competitions, the 23-day event brings together 4-H and FFA participants, livestock enthusiasts, and families to celebrate North Texas’ rich Western heritage.
